Joanna Marco, MD
Rheumatology · Pittsburgh, PANPI 1700272556
Payments from drug & device makers
Across 32 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$189
- Boehringer Ingelheim$155
- Genentech USA, Inc.$100
- Novartis$98
- Pfizer$74
- GSK$43
- plus $66 from 3 others
What the payments were for
- Food & beverage$62686%
- Education$10014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $189 |
| Boehringer Ingelheim | 3 | $155 |
| Genentech USA, Inc. | 1 | $100 |
| Novartis | 6 | $98 |
| Pfizer | 3 | $74 |
| GSK | 2 | $43 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Sobi, Inc | 1 | $19 |
How this compares
$726 in reported general payments places this provider in the 35th percentile of 351 rheumatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $154,906 |
| OtezlaApremilast | 29 | $145,203 |
| Orencia ClickjectAbatacept | 20 | $113,822 |
| Cosentyx Sensoready PenSecukinumab | 12 | $85,020 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 14 | $43,610 |
| Mycophenolate Mofetil | 76 | $10,429 |
| Hydroxychloroquine Sulfate | 131 | $4,420 |
| MethotrexateMethotrexate Sodium | 157 | $4,328 |
| Leflunomide | 47 | $2,702 |
| Azathioprine | 31 | $1,484 |
| Pilocarpine Hcl | 16 | $1,439 |
| Colchicine | 30 | $847 |
| Celecoxib | 21 | $716 |
| Prednisone | 136 | $498 |
| Duloxetine Hcl | 26 | $451 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Pittsburgh
- Rohit AggarwalPittsburgh$6.2M
- Siamak Moghadam-KiaPittsburgh$1.9M
- Chester OddisPittsburgh$646K
- Andreea CocaPittsburgh$551K
- Sebastian Sattui CortesPittsburgh$542K
- Susan ManziPittsburgh$468K
- Michael LuckePittsburgh$292K
- Tarun SharmaPittsburgh$275K
- Robyn DomsicPittsburgh$190K
- Kimberly LiangPittsburgh$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.